At Elicio, we’re excited about our work, and look forward to sharing information about it with you. Please feel free to get in touch with us.

451 D Street
5th Floor, Suite 501
Boston, MA 02210


Phone: +1 857 209-0050

For information about our clinical trials, please visit

AMPLIFY-201: First in Human Phase 1/2 Trial of ELI-002 Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors (Protocol Number: ELI-002-001)

Enrolling RAS mutated pancreatic, colorectal, lung, mucinous ovarian, bile duct and gallbladder tumors

For further questions about the trials, contact one of our participating sites listed on